Back

Inositol 1,4,5-trisphosphate receptors (ITP3Rs) ablation reduces the expression of chemokine ligands and pro-inflammatory interleukins

20 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Advances in mechanisms of heart failure Pathophysiology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Urna Kansakar

Albert Einstein College of Medicine, Bronx (United States of America)

6 More presentations in this session

Presentation thumbnail
Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure
Doctor N. De Biase (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Immune cell signature in non-ischemic heart failure indicates chronic activation and immunosenescence
Mr L. Baumhove (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Miss J. Zhang (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
The role of EDEM2 in the heart under metabolic stress
Miss O. Fonseka (Manchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in mechanisms of heart failure

The Event

Event poster

Heart Failure 2025

20 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Elucidating the role of Inositol 1,4,5-triphosphate receptors (IP3Rs) in modulating the regulation of cardiac myofibroblasts
thumbnail
Congress Session
Inflammation in heart failure
thumbnail
Congress Presentation
The different faces of inflammation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources